View in Other Languages 
Sydney, Dec 21, 2009 (ABN Newswire) - Stirling Resources (ASX:SRE) will issue a new share entitlement issue Prospectus to raise approximately A$9.8 million to complete the recapitalisation of Monarch Gold (ASX:MON)(PINK:MARCF). The new Offer is being made as a Renounceable Entitlement issue of one new share for every share currently held, with an issue price of A$0.15 per share. It will also include one free attaching option for every new share issued, with a strike price of A$0.15. The Offer is expected to close on 22 January 2010.
Conquest Mining Limited (ASX:CQT)(PINK:CQMLF) has announced the appointment of Paul Marks, BEng(Chem), MAppFin, as a Non-Executive Director of the Company. Mr Marks' has 35 years of experience across a range of industries from foreign exchange and commodities trading, oil and gas downstream production and chemical hydrocarbon processing. Conquest's Managing Director, John Terpu, welcomed Mr Marks' appointment, saying it was part of the evolutionary process for the Company which added significant commercial and technical strengths to the Conquest board.
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.
SBI E2-Capital maintained Fufeng (HKG:0546)(PINK:FFNGY) rating at 'buy', and set its target price at 5.98 Hong Kong dollars. SBI E2-Capital estimated Fufeng will record RMB 915.3 million in 2009. Stronger-than-expected corn price and industry consolidation will be the growth momentum of Fufeng in the following several years, which MSG price surged from RMB7,719 per tonne in September 2009 to RMB10,200 in November 2009, according to the report.
Conquest Mining Limited (ASX:CQT)(PINK:CQMLF) has announced the appointment of Paul Marks, BEng(Chem), MAppFin, as a Non-Executive Director of the Company. Mr Marks' has 35 years of experience across a range of industries from foreign exchange and commodities trading, oil and gas downstream production and chemical hydrocarbon processing. Conquest's Managing Director, John Terpu, welcomed Mr Marks' appointment, saying it was part of the evolutionary process for the Company which added significant commercial and technical strengths to the Conquest board.
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.
SBI E2-Capital maintained Fufeng (HKG:0546)(PINK:FFNGY) rating at 'buy', and set its target price at 5.98 Hong Kong dollars. SBI E2-Capital estimated Fufeng will record RMB 915.3 million in 2009. Stronger-than-expected corn price and industry consolidation will be the growth momentum of Fufeng in the following several years, which MSG price surged from RMB7,719 per tonne in September 2009 to RMB10,200 in November 2009, according to the report.
|
||
|
 |
Related Companies |
>>>            Conquest Mining Limited>>> Fufeng Group Limited>>> Mesoblast Limited>>> Monarch Gold Mining Company Limited>>> Stirling Resources Limited |
| |
Related Industry Topics: |
Food & Beverage | Biotech | Financial General | Health & Pharm General | Mining | |
| |
This Page Viewed: (Last 7 Days: 180) (Last 30 Days: 710) (Since Published: 48780) |
(278600)
Events & Exhibitions
|
Site Search
| ENGLISH All Languages |
|
Fufeng Group Limited | ||||||
|
|||||||
|
Mesoblast Limited | ||||||
|
|||||||
AJAX UNION |
|||
|
|||
Companies in the News
ABN Newswire on iPhone/iPad
|
| Download from Apple |
Mobile Video TV
|
||
|
||
){kind=link}